AQU-118

N/A

Report date: 2025/01/26 15:07:08
NME

Base Information

Drug NameAQU-118
Drug Alias Namedual active MMP-2/-9 inhibitors (Aquilus Pharmaceuticals)AQU-118
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMatrix metalloproteinase-2 inhibitorsMatrix metalloproteinase 9 inhibitors
TargetsMatrix metalloproteinase 9Matrix metalloproteinase-2
Therapy Area/IndicationsPainNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAquilus Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesAquilus Pharmaceuticals
Inactive CompaniesN/A
Active IndicationsPainNeuralgia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A